Failure of Bcl-2 to block cytochrome c redistribution during TRAIL-induced apoptosis

被引:100
作者
Keogh, SA
Walczak, H
Bouchier-Hayes, L
Martin, SJ [1 ]
机构
[1] Univ Dublin Trinity Coll, Dept Genet, Smurfit Inst Genet, Mol Cell Biol Lab, Dublin 2, Ireland
[2] German Canc Res Ctr, Div Tumor Immunol, D-6900 Heidelberg, Germany
基金
英国惠康基金;
关键词
apoptosis; Bcl-2; BID; caspase; cytochrome c; tumor necrosis factor-related apoptosis-inducing ligand;
D O I
10.1016/S0014-5793(00)01375-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF family of cytokines that promotes apoptosis and NF-kappa B activation. Here we show that recombinant hu-TRAIL initiates the activation of multiple caspases, the loss of mitochondrial transmembrane potential, the cleavage of BID and the redistribution of mitochondrial cytochrome c. However, whereas Bcl-2 efficiently blocked UV radiation-induced cytochrome c release and consequent apoptosis of CEM cells, it failed to do either in the context of TRAIL treatment. Thus, TRAIL engages a death pathway that is at least partially routed via the mitochondria, but in contrast with other stimuli that engage this pathway, TRAIL-induced cytochrome c release is not regulated by Bcl-2. (C) 2000 Federation of European Biochemical Societies.
引用
收藏
页码:93 / 98
页数:6
相关论文
共 49 条
[1]   Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death [J].
Boldin, MP ;
Goncharov, TM ;
Goltsev, YV ;
Wallach, D .
CELL, 1996, 85 (06) :803-815
[2]   Apoptosis induced by microinjection of cytochrome c is caspase-dependent and is inhibited by Bcl-2 [J].
Brustugun, OT ;
Fladmark, KE ;
Doskeland, SO ;
Orrenius, S ;
Zhivotovsky, B .
CELL DEATH AND DIFFERENTIATION, 1998, 5 (08) :660-668
[3]  
Castedo M, 1996, J IMMUNOL, V157, P512
[4]   Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway [J].
Chaudhary, PM ;
Eby, M ;
Jasmin, A ;
Bookwalter, A ;
Murray, J ;
Hood, L .
IMMUNITY, 1997, 7 (06) :821-830
[5]   Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family [J].
DegliEsposti, MA ;
Smolak, PJ ;
Walczak, H ;
Waugh, J ;
Huang, CP ;
DuBose, RF ;
Goodwin, RG ;
Smith, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) :1165-1170
[6]   Mitochondria and apoptosis [J].
Green, DR ;
Reed, JC .
SCIENCE, 1998, 281 (5381) :1309-1312
[7]  
Griffith TS, 1998, J IMMUNOL, V161, P2833
[8]   TRAIL: a molecule with multiple receptors and control mechanisms [J].
Griffith, TS ;
Lynch, DH .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (05) :559-563
[9]   Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death [J].
Gross, A ;
Yin, XM ;
Wang, K ;
Wei, MC ;
Jockel, J ;
Millman, C ;
Erdjument-Bromage, H ;
Tempst, P ;
Korsmeyer, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (02) :1156-1163
[10]   Cancer research - How TRAIL kills cancer cells, but not normal cells [J].
Gura, T .
SCIENCE, 1997, 277 (5327) :768-768